Emily A Sloan, MD,PhD| Pathology | MedStar Health

Emily A Sloan, MD,PhD
Provider is directly employed by MedStar Health

Specialties: Pathology

Languages: English

This doctor does not schedule patient visits.

About me

Emily A. Sloan, MD, PhD, is Associate Director of Neuropathology at the MedStar Comprehensive Brain Tumor Center and Department of Pathology at MedStar Georgetown University Hospital. As a diagnostic neuropathologist, her clinical focus is on diseases of the central nervous system, with an emphasis on neoplastic disease and the grading and classification of CNS tumors. She also has expertise in neuromuscular pathology and autopsy pathology. She is triple board certified in Neuropathology, Anatomic Pathology, and Clinical Pathology.

Dr. Sloan is a member of multiple societies including the American Association of Neuropathologists, College of American Pathologists, and United States and Canadian Academy of Pathology. She has published more than 25 basic science and translational research studies in peer-reviewed journals. With this knowledge, she integrates histopathologic classification and molecular informatics to ensure her patients receive the best possible diagnostic care.

Dr. Sloan also actively participates in education of residents, fellows, and medical students, receiving a teaching award for Resident Education. She earned her Ph.D in Microbiology, Immunology and Cancer Biology investigating the molecular genetics of HIV infection, and maintains a strong interest in infectious diseases and health equity.

Dr. Sloan’s main areas of clinical expertise include:

  • Expert diagnostic services in neuro-oncology, inflammatory/autoimmune disease, infectious processes, muscle and nerve disorders, and neurodegenerative disease
  • Rapid intraoperative consultations
  • Post-mortem neuropathologic brain examinations, including evaluation of neurodegenerative diseases, as well as general autopsy services
  • Ancillary techniques including histochemistry, immunohistochemistry, ultrastructural evaluation, and molecular genetics for integrated tumor classification

Conditions and procedures

Conditions I treat

  • Acoustic Neuroma
  • Anaplastic Astrocytoma
  • Anaplastic Ependymoma
  • Arachnoid Cyst
  • Benign Neoplasm Of Brain
  • Brain And Spine Tumors
  • Brain Neoplasms
  • Cavernous Hemangioma
  • Central Nervous System Abscess
  • Central Nervous System Infection
  • Central Nervous System Malignancy
  • Central Nervous System Tumors
  • Cerebral Anomalies
  • Cerebral Hemorrhage
  • Clivus Chondroma
  • Demyelinating Disease
  • Dural Based Tumor
  • Embryonal Cell Tumors Of The Brain
  • Embryonal Tumors
  • Endodermal Sinus Tumor
  • Ganglioneuroblastoma
  • Genetic Disorders
  • Glioblastoma Multiforme
  • Leptomeningeal Carcinomatosis
  • Malignant Brain Neoplasm
  • Malignant Neoplasm Of Brain Stem
  • Malignant Neoplasm Of The Spinal Cord
  • Medulloepithelioma
  • Meningioma
  • Metastatic Brain Cancer
  • Muscular Dystrophy
  • Nasopharyngeal Angiofibroma
  • Neuroendocrine Tumors
  • Rhabdoid Tumor Predisposition Syndrome
  • Spinal Cord Tumors
  • Tuberous Sclerosis
  • Turcot Syndrome
  • Vertebral Hemangioma
  • Von Hippel Lindau Disease
Show All Show Less

Procedures I perform

  • Autopsy
  • Brain Cancer Genomics
  • Cancer Genetics
  • Immunogenetics
  • Next Generation Sequencing
  • Tumor Pathology
  • Whole Genome Sequencing
Show All button Press enter to expand Show Less

Practice locations

Distance from Change LocationEnter your Location

3800 Reservoir Road Northwest
Suite 201
Washington, DC, 20007

202-687-5307

Fax 703-558-1442

Get Directions

miles away

Fax 703-558-1442

Insurance

MedStar Health accepts most major health insurance plans. If you are uncertain as to whether your individual health insurance plan is accepted at MedStar Health, please call your insurance company.

  • List of insurance plans we accept
    • United Healthcare Options (PPO) (includes Empire PPO, GEHA, Compass Rose)
    • Blue Choice Advantage & Healthy Blue (HMO, POS)
    • Kaiser Permanente Medicare Advantage Signature and Select (aka Senior Advantage)
    • UnitedHealthcare and AARP Medicare Complete Plans/ UHC Group Medicare Advantage Plans HMO, POS, PPO
    • UnitedHealthcare Medicare Adv/Special Needs Plans
    • UHC Community Plan of MD
    • Private Health Care Systems (PHCS) (PPO)
    • Medicare Fee for Service
    • Kaiser Virginia Premier
    • Kaiser PermanenteSelect-Added Choice
    • Kaiser Permanente Signature-Added Choice
    • Kaiser Permanente Signature
    • Kaiser Permanente Select
    • Kaiser Permanente Medicare Plus (Medicare Supplemental Plan)
    • Kaiser Permanente Flexible Choice POS
    • Kaiser MD Medicaid MCO
    • CFBCBS Federal Employee Program (Std/Basic PPO/Blue Focus)
    • CFBCBS EPO
    • Aetna Innovations: HMO & EPO Plus
    • Select HMO/HealthFund/Health Network
    • Aetna HMO
    • Open POS II
    • Innovation Health: Open POS Plus
    • Choice POS & Choice POS II
    • Aetna Managed Choice Open Access (POS)
    • Open EPO Plus
    • Opoen HMO Option
    • Open HMO
    • Innovation Health: POS
    • Aetna HMO-Open Access/Select OA/HealthFund/Health Network Option OA
    • Innovation Health: Open Network Only Plus
    • Aetna Elect Choice/ Open Access (POS)
    • Innovation Health: POS Plus
    • Aetna Managed Choice (POS)
    • Innovation Health: PPO
    • Aetna Open Choice (PPO)
    • Innovation Health: Indemnity
    • Aetna Traditional Choice (PPO)
    • BlueChoice Open Access
    • CFBCBS Blue Choice Opt Out Open Access
    • HealthyBlue PPO
    • CFBSBC Blue Preferred PPO
    • Choice Fund PPO
    • PPO and PPO Plus
    • CIGNA EPO
    • POS OA & OA Plus
    • Network OA
    • CIGNA HMO Open Access (OA)
    • United Healthcare Choice
    • Mamsi Life & Health (Indem./PPO)
    • Optimum Choice Preferred (POS) & OCI Direct (HMO)
    • M.D. IPA Preferred (POS)
    • M.D. IPA (HMO)
    • United Student Resources
    • United Healthcare Choice Plus
    • United Healthcare Select Plus (POS)
    • United Healthcare Select HMO - EPO/NPP
    • Tricare for Life (Medicare Supplemental Plan)
    • Tricare Prime
    • MedStar Select (MedStar Associates' Plan)
    • MedStar Family Choice - Maryland Health Choice
    • FIRST HEALTH
    • Coventry Health Care National Network PPO
    • First Health PPO
    • Coventry of Delaware HMO/PPO
    • Coventry Health Care of Virginia
    • CIGNA Indemnity
    • Great-West Healthcare POS/CIGNA
    • CIGNA POS/Network POS
    • CIGNA HMO & Network (HMO)
    • CFBCBS (NCA) Indemnity
    • CFBCBS Maryland Indemnity or PPO
    • CFBCBS Maryland Point of Service Plan (MPOS)
    • CFBCBS Blue Choice Opt Out Plus Open Access (POS)
    • CFBCBS BlueChoice HMO
    • Aetna Worker's Compensation Network
    • Aetna Medicare Advantage HMO & PPO Plans
    • Aetna Student Health Insurance
    • Aetna Quality Point of Service (POS)
    • Aetna Elect Choice/ EPO (Aetna Health Fund) Innovation Health: Network Only Plus

Education

Board Certification: American Board of Pathology, Anatomic Pathology

Board Certification: American Board of Pathology, Clinical Pathology

Board Certification: American Board of Pathology, Neuropathology

Fellowship Program: University of California San Francisco (2020)

Residency Program: University of Virginia Hospitals (2018)

Medical School: University of Virginia School of Medicine (2014)

Awards

  • Resident Teaching Award, MedStar Georgetown Department of Pathology (2022)
  • Moore Award for best clinico-pathologic paper in neuropathology, American Association of Neuropathologists (AANP) (2020)
  • O.T. Bailey-Helena Riggs Award, AANP Diagnostic Slide Session (2019)

News and publications


  • Sloan EA, Gupta R, Koelsche C, Chiang J, Villanueva-Meyer JE, Alexandrescu S, Eschbacher JM, Wang W, Mafra M, Ud Din N, Carr-Boyd E, Watson M, Punsoni M, Oviedo A, Gilani A, Kleinschmidt-DeMasters BK, Coss DJ, Lopes MB, Reddy A, Mueller S, Cho SJ, Horvai AE, Lee JC, Pekmezci M, Tihan T, Bollen AW, Rodriguez FJ, Ellison DW, Perry A, von Deimling A, Chang SM, Berger MS, Solomon DA. Intracranial mesenchymal tumors with FET-CREB fusion are composed of at least two epigenetic subgroups distinct from meningioma and extracranial sarcomas. Brain Pathol. 2022 Jul;32(4):e13037. doi: 10.1111/bpa.13037. Epub 2021 Nov 25. PMID: 34821426; PMCID: PMC9245938.

  • Sloan EA, Chiang J, Villanueva-Meyer JE, Alexandrescu S, Eschbacher JM, Wang W, Mafra M, Ud Din N, Carr-Boyd E, Watson M, Punsoni M, Oviedo A, Gilani A, Kleinschmidt-DeMasters BK, Coss DJ, Lopes MB, Raffel C, Berger MS, Chang SM, Reddy A, Ramani B, Ferris SP, Lee JC, Hofmann JW, Cho SJ, Horvai AE, Pekmezci M, Tihan T, Bollen AW, Rodriguez FJ, Ellison DW, Perry A, Solomon DA. Intracranial mesenchymal tumor with FET-CREB fusion-A unifying diagnosis for the spectrum of intracranial myxoid mesenchymal tumors and angiomatoid fibrous histiocytoma-like neoplasms. Brain Pathol. 2021 Jul;31(4):e12918. doi: 10.1111/bpa.12918. Epub 2021 Jan 28. PMID: 33141488; PMCID: PMC8089120.

  • Lucas CG, Sloan EA, Gupta R, Wu J, Pratt D, Vasudevan HN, Ravindranathan A, Barreto J, Williams EA, Shai A, Whipple NS, Bruggers CS, Maher O, Nabors B, Rodriguez M, Samuel D, Brown M, Carmichael J, Lu R, Mirchia K, Sullivan DV, Pekmezci M, Tihan T, Bollen AW, Perry A, Banerjee A, Mueller S, Gupta N, Hervey-Jumper SL, Oberheim Bush NA, Daras M, Taylor JW, Butowski NA, de Groot J, Clarke JL, Raleigh DR, Costello JF, Phillips JJ, Reddy AT, Chang SM, Berger MS, Solomon DA. Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1. Acta Neuropathol. 2022 Oct;144(4):747-765. doi: 10.1007/s00401-022-02478-5. Epub 2022 Aug 9. PMID: 35945463; PMCID: PMC9468105.

  • Yeh J, Marks JA, Alzeer AH, Sloan EA, Varghese R, Paudel N, Reuss JE, Bergquist PJ, Liu SV, Kim C. Remarkable Intracranial Response to Sotorasib in a Patient With KRASG12C-Mutated Lung Adenocarcinoma and Untreated Brain Metastases: A Case Report. JTO Clin Res Rep. 2022 Nov 6;3(12):100428. doi: 10.1016/j.jtocrr.2022.100428. PMID: 36471683; PMCID: PMC9719091.

  • Alonzo CJ, Burnsed JC, Sloan EA, Zanelli SA. A Term Infant with Encephalopathy and Severe Leukocytosis. Neoreviews. 2022 Aug 1;23(8):e579-e581. doi: 10.1542/neo.23-8-e579. PMID: 35909106.

  • Mehta A, Khan F, Wagner C, Hashemzadeh T, Stemer A, Sloan EA, Mayson D, Amjad F. A Case of Neurosarcoid Presenting as Multiple Intraparenchymal Hemorrhages. Neurohospitalist. 2022 Jan;12(1):162-166. doi: 10.1177/19418744211029495. Epub 2021 Jun 30. PMID: 34950407; PMCID: PMC8689526.

  • Pekmezci M, Morshed RA, Chunduru P, Pandian B, Young J, Villanueva-Meyer JE, Tihan T, Sloan EA, Aghi MK, Molinaro AM, Berger MS, Hervey-Jumper SL. Detection of glioma infiltration at the tumor margin using quantitative stimulated Raman scattering histology. Sci Rep. 2021 Jun 9;11(1):12162. doi: 10.1038/s41598-021-91648-8. PMID: 34108566; PMCID: PMC8190264.

  • Ramani B, Gupta R, Wu J, Barreto J, Bollen AW, Tihan T, Mummaneni PV, Ames C, Clark A, Oberheim Bush NA, Butowski N, Phillips D, King BE, Bator SM, Treynor EC, Zherebitskiy V, Quinn PS, Walker JB, Pekmezci M, Sullivan DV, Hofmann JW, Sloan EA, M Chang S, Berger MS, Solomon DA, Perry A. The immunohistochemical, DNA methylation, and chromosomal copy number profile of cauda equina paraganglioma is distinct from extra-spinal paraganglioma. Acta Neuropathol. 2020 Dec;140(6):907-917. doi: 10.1007/s00401-020-02221-y. Epub 2020 Sep 6. PMID: 32892244; PMCID: PMC7682537.

  • Ramani B, Gupta R, Wu J, Barreto J, Bollen AW, Tihan T, Mummaneni PV, Ames C, Clark A, Oberheim Bush NA, Butowski N, Phillips D, King BE, Bator SM, Treynor EC, Zherebitskiy V, Quinn PS, Walker JB, Pekmezci M, Sullivan DV, Hofmann JW, Sloan EA, M Chang S, Berger MS, Solomon DA, Perry A. The immunohistochemical, DNA methylation, and chromosomal copy number profile of cauda equina paraganglioma is distinct from extra-spinal paraganglioma. Acta Neuropathol. 2020 Dec;140(6):907-917. doi: 10.1007/s00401-020-02221-y. Epub 2020 Sep 6. PMID: 32892244; PMCID: PMC7682537.

  • Sloan EA, Sampognaro PJ, Junn JC, Chin C, Jacques L, Ramachandran PS, DeRisi JL, Wilson MR, Kriegstein AR, Bollen AW, Solomon DA, Margeta M, Engstrom JW. Neuroglial stem cell-derived inflammatory pseudotumor (n-SCIPT): clinicopathologic characterization of a novel lesion of the lumbosacral spinal cord and nerve roots following intrathecal allogeneic stem cell intervention. Acta Neuropathol. 2019 Dec;138(6):1103-1106. doi: 10.1007/s00401-019-02089-7. Epub 2019 Oct 28. PMID: 31659431; PMCID: PMC6858593.

  • Sloan EA, Cooney T, Oberheim Bush NA, Buerki R, Taylor J, Clarke JL, Torkildson J, Kline C, Reddy A, Mueller S, Banerjee A, Butowski N, Chang S, Mummaneni PV, Chou D, Tan L, Theodosopoulos P, McDermott M, Berger M, Raffel C, Gupta N, Sun PP, Li Y, Shah V, Cha S, Braunstein S, Raleigh DR, Samuel D, Scharnhorst D, Fata C, Guo H, Moes G, Kim JYH, Koschmann C, Van Ziffle J, Onodera C, Devine P, Grenert JP, Lee JC, Pekmezci M, Phillips JJ, Tihan T, Bollen AW, Perry A, Solomon DA. Recurrent non-canonical histone H3 mutations in spinal cord diffuse gliomas. Acta Neuropathol. 2019 Nov;138(5):877-881. doi: 10.1007/s00401-019-02072-2. Epub 2019 Sep 12. PMID: 31515627; PMCID: PMC6818961.

  • Sloan EA, Hilz S, Gupta R, Cadwell C, Ramani B, Hofmann J, Kline CN, Banerjee A, Reddy A, Oberheim Bush NA, Chang S, Braunstein S, Chang EF, Raffel C, Gupta N, Sun PP, Kim JYH, Moes G, Alva E, Li R, Bruggers CS, Alashari M, Wetmore C, Garg S, Dishop M, Van Ziffle J, Onodera C, Devine P, Grenert JP, Lee JC, Phillips JJ, Pekmezci M, Tihan T, Bollen AW, Berger MS, Costello JF, Perry A, Solomon DA. Gliomas arising in the setting of Li-Fraumeni syndrome stratify into two molecular subgroups with divergent clinicopathologic features. Acta Neuropathol. 2020 May;139(5):953-957. doi: 10.1007/s00401-020-02144-8. Epub 2020 Mar 10. PMID: 32157385; PMCID: PMC7183424.